Compared with the concordant group, patients in the non-albumin-predominant group were older with lower BMI besides having a higher prevalence of diabetes, hypertension, CVD, and cancer, and a higher likelihood of exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) or contrast (Table 1). This evidence concerns the gene ALB and cancer.